R01 CA138212/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2009	1
2010	3
2011	7
2012	4
2013	4
2014	8
2015	6
2016	3
2017	1
2019	1
2024	0

1

Assemblages: functional units formed by cellular phase separation.

Toretsky JA, Wright PE. Toretsky JA, et al. J Cell Biol. 2014 Sep 1;206(5):579-88. doi: 10.1083/jcb.201404124. J Cell Biol. 2014. PMID: 25179628 Free PMC article. Review.

2

Oncogenic partnerships: EWS-FLI1 protein interactions initiate key pathways of Ewing's sarcoma.

Erkizan HV, Uversky VN, Toretsky JA. Erkizan HV, et al. Clin Cancer Res. 2010 Aug 15;16(16):4077-83. doi: 10.1158/1078-0432.CCR-09-2261. Epub 2010 Jun 14. Clin Cancer Res. 2010. PMID: 20547696 Free PMC article. Review.

3

RNA helicase DDX3: a novel therapeutic target in Ewing sarcoma.

Wilky BA, Kim C, McCarty G, Montgomery EA, Kammers K, DeVine LR, Cole RN, Raman V, Loeb DM. Wilky BA, et al. Oncogene. 2016 May 19;35(20):2574-83. doi: 10.1038/onc.2015.336. Epub 2015 Sep 14. Oncogene. 2016. PMID: 26364611

4

YK-4-279 inhibits ERG and ETV1 mediated prostate cancer cell invasion.

Rahim S, Beauchamp EM, Kong Y, Brown ML, Toretsky JA, Üren A. Rahim S, et al. PLoS One. 2011 Apr 29;6(4):e19343. doi: 10.1371/journal.pone.0019343. PLoS One. 2011. PMID: 21559405 Free PMC article.

5

LGR5 is Expressed by Ewing Sarcoma and Potentiates Wnt/β-Catenin Signaling.

Scannell CA, Pedersen EA, Mosher JT, Krook MA, Nicholls LA, Wilky BA, Loeb DM, Lawlor ER. Scannell CA, et al. Front Oncol. 2013 Apr 15;3:81. doi: 10.3389/fonc.2013.00081. eCollection 2013. Front Oncol. 2013. PMID: 23596566 Free PMC article.

6

YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model.

Minas TZ, Han J, Javaheri T, Hong SH, Schlederer M, Saygideğer-Kont Y, Çelik H, Mueller KM, Temel I, Özdemirli M, Kovar H, Erkizan HV, Toretsky J, Kenner L, Moriggl R, Üren A. Minas TZ, et al. Oncotarget. 2015 Nov 10;6(35):37678-94. doi: 10.18632/oncotarget.5520. Oncotarget. 2015. PMID: 26462019 Free PMC article.

7

Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells.

Bulut G, Hong SH, Chen K, Beauchamp EM, Rahim S, Kosturko GW, Glasgow E, Dakshanamurthy S, Lee HS, Daar I, Toretsky JA, Khanna C, Uren A. Bulut G, et al. Oncogene. 2012 Jan 19;31(3):269-81. doi: 10.1038/onc.2011.245. Epub 2011 Jun 27. Oncogene. 2012. PMID: 21706056 Free PMC article.

8

Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNA.

Hayashi M, Chu D, Meyer CF, Llosa NJ, McCarty G, Morris CD, Levin AS, Wolinsky JP, Albert CM, Steppan DA, Park BH, Loeb DM. Hayashi M, et al. Cancer. 2016 Oct;122(19):3015-23. doi: 10.1002/cncr.30144. Epub 2016 Jun 28. Cancer. 2016. PMID: 27351911 Free PMC article.

9

PBX1 is a favorable prognostic biomarker as it modulates 13-cis retinoic acid-mediated differentiation in neuroblastoma.

Shah N, Wang J, Selich-Anderson J, Graham G, Siddiqui H, Li X, Khan J, Toretsky J. Shah N, et al. Clin Cancer Res. 2014 Aug 15;20(16):4400-12. doi: 10.1158/1078-0432.CCR-13-1486. Epub 2014 Jun 19. Clin Cancer Res. 2014. PMID: 24947929 Free PMC article.

10

Acetylation Increases EWS-FLI1 DNA Binding and Transcriptional Activity.

Schlottmann S, Erkizan HV, Barber-Rotenberg JS, Knights C, Cheema A, Uren A, Avantaggiati ML, Toretsky JA. Schlottmann S, et al. Front Oncol. 2012 Sep 7;2:107. doi: 10.3389/fonc.2012.00107. eCollection 2012. Front Oncol. 2012. PMID: 22973553 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

33 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year